May 2017

Late last week, California passed legislation in the state senate that restricts pharmaceutical companies from giving gifts and…

The purpose of this article is to give manufacturers some initial background on the topics and some tools that could be…

As has been noted, CMS named 769 hospitals that will face Medicare payment cuts in fiscal year (FY) 2017 under the…

Although the new code of conduct for member medical device and in-vitro diagnostic companies operating in the European marketplace…

On April 28, 2017, the United States Department of Justice announced a settlement with Quest Diagnostics, Inc., for $6 million to…

On April 24, 2017, Sanofi-Aventis sued Mylan Inc. in a United States District Court in New Jersey over its effort to keep a rival…

Over the last several years, the pharmaceutical industry has seen a steady increase in state legislation targeting the cost of…

We have long been known to deride the national Open Payments database, believing that it does more harm than good. Recently, it…

Over the last two years, bipartisan Congressional interest in addressing prescription drug prices has been piqued. The interest is…

During the Medicare Payment Advisory Commission (MedPAC) April meeting, Commissioners discussed the medical device market. Since…